These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33450404)
21. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802 [TBL] [Abstract][Full Text] [Related]
22. Rational Vaccine Design in the Time of COVID-19. Burton DR; Walker LM Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707 [TBL] [Abstract][Full Text] [Related]
23. The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate. Garassino MC; Vyas M; de Vries EGE; Kanesvaran R; Giuliani R; Peters S; Ann Oncol; 2021 May; 32(5):579-581. PubMed ID: 33582237 [No Abstract] [Full Text] [Related]
24. SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants. Moore JP; Offit PA JAMA; 2021 Mar; 325(9):821-822. PubMed ID: 33507218 [No Abstract] [Full Text] [Related]
25. Coronavirus vaccines get a biotech boost. Dance A Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847 [No Abstract] [Full Text] [Related]
27. 'I've never worked harder': the race to develop a COVID-19 vaccine. Woolston C Nature; 2020 Nov; 587(7833):322. PubMed ID: 33168971 [No Abstract] [Full Text] [Related]
28. [Not Available]. Kokkinakis I Rev Med Suisse; 2021 Aug; 17(746):1379. PubMed ID: 34397187 [No Abstract] [Full Text] [Related]
29. Development of vaccines for SARS-CoV-2. Ng WH; Liu X; Mahalingam S F1000Res; 2020; 9():. PubMed ID: 32850116 [TBL] [Abstract][Full Text] [Related]
31. [Immunological research of COVID-19 and emerging infectious diseases]. Cao XT Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(1):1-6. PubMed ID: 33423443 [TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 vaccines are not free of neurological side effects. Finsterer J; Scorza FA Acta Neurol Scand; 2021 Jul; 144(1):109-110. PubMed ID: 34002379 [No Abstract] [Full Text] [Related]
33. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Barrière J; Gal J; Hoch B; Cassuto O; Leysalle A; Chamorey E; Borchiellini D Ann Oncol; 2021 May; 32(5):673-674. PubMed ID: 33529740 [No Abstract] [Full Text] [Related]
34. COVID-19 vaccines-The way forward. Klimek L; Agache I; Cooke E; Jutel M; Akdis CA; O'Hehir R Allergy; 2022 Jan; 77(1):15-16. PubMed ID: 34191300 [No Abstract] [Full Text] [Related]
35. Understanding the determinants of acceptance of COVID-19 vaccines: a challenge in a fast-moving situation. Verger P; Peretti-Watel P Lancet Public Health; 2021 Apr; 6(4):e195-e196. PubMed ID: 33556329 [No Abstract] [Full Text] [Related]
36. Adapting Cancer Civil Society Organizations to Accelerate COVID-19 Vaccinations in People Living With Cancer in Low- and Middle-Income Countries-A Commentary. Munisamy M; Ndoh K; Abdelbadee A; Espejo I; Manjuh F; Tamas A; Salako O; Roitberg F JCO Glob Oncol; 2021 Jul; 7():1194-1198. PubMed ID: 34292779 [No Abstract] [Full Text] [Related]
37. COVID-19, cults, and the anti-vax movement. Mylan S; Hardman C Lancet; 2021 Mar; 397(10280):1181. PubMed ID: 33773626 [No Abstract] [Full Text] [Related]